These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 15572708

  • 1. Adolescents with depression.
    Rifkin A, Rifkin W.
    JAMA; 2004 Dec 01; 292(21):2577-8; author reply 2578-9. PubMed ID: 15572708
    [No Abstract] [Full Text] [Related]

  • 2. Adolescents with depression.
    Carroll BJ.
    JAMA; 2004 Dec 01; 292(21):2578; author reply 2578-9. PubMed ID: 15572711
    [No Abstract] [Full Text] [Related]

  • 3. Adolescents with depression.
    Bridge JA, Brent DA.
    JAMA; 2004 Dec 01; 292(21):2578; author reply 2578-9. PubMed ID: 15572710
    [No Abstract] [Full Text] [Related]

  • 4. Adolescents with depression.
    Antonuccio D, Burns D.
    JAMA; 2004 Dec 01; 292(21):2577; author reply 2578-9. PubMed ID: 15572709
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of adolescents with major depression: contributions of a major trial.
    Glass RM.
    JAMA; 2004 Aug 18; 292(7):861-3. PubMed ID: 15316001
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of adolescent depression: what we have come to know.
    Vitiello B.
    Depress Anxiety; 2009 Aug 18; 26(5):393-5. PubMed ID: 19404989
    [No Abstract] [Full Text] [Related]

  • 7. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.
    March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J, Treatment for Adolescents With Depression Study (TADS) Team.
    JAMA; 2004 Aug 18; 292(7):807-20. PubMed ID: 15315995
    [Abstract] [Full Text] [Related]

  • 8. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
    Goodyer IM, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R.
    Health Technol Assess; 2008 May 18; 12(14):iii-iv, ix-60. PubMed ID: 18462573
    [Abstract] [Full Text] [Related]

  • 9. Prescribing for depressed adolescents: office decision-making in the face of limited research evidence.
    Gordon M, Melvin GA.
    J Paediatr Child Health; 2014 Jul 18; 50(7):498-503. PubMed ID: 24617419
    [No Abstract] [Full Text] [Related]

  • 10. [A place for SSRIs in the treatment of severely depressed children and adolescents].
    Andeweg J, van Grinsven M.
    Ned Tijdschr Geneeskd; 2008 Oct 25; 152(43):2366; author reply 2366. PubMed ID: 19024070
    [No Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness of depression treatment for adolescents.
    Norquist G, McGuire TG, Essock SM.
    Am J Psychiatry; 2008 May 25; 165(5):549-52. PubMed ID: 18450932
    [No Abstract] [Full Text] [Related]

  • 12. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial.
    Davey CG, Chanen AM, Cotton SM, Hetrick SE, Kerr MJ, Berk M, Dean OM, Yuen K, Phelan M, Ratheesh A, Schäfer MR, Amminger GP, Parker AG, Piskulic D, Harrigan S, Mackinnon AJ, Harrison BJ, McGorry PD.
    Trials; 2014 Nov 04; 15():425. PubMed ID: 25370185
    [Abstract] [Full Text] [Related]

  • 13. Benefits and harms of pediatric antidepressant medications.
    Edwards JL, Kirk KK, Midha CK.
    JAMA; 2007 Aug 08; 298(6):626-7; author reply 627. PubMed ID: 17684183
    [No Abstract] [Full Text] [Related]

  • 14. Continuation cognitive-behavioural therapy maintains attributional style improvement in depressed patients responding acutely to fluoxetine.
    Petersen T, Harley R, Papakostas GI, Montoya HD, Fava M, Alpert JE.
    Psychol Med; 2004 Apr 08; 34(3):555-61. PubMed ID: 15259840
    [Abstract] [Full Text] [Related]

  • 15. Turning darkness into light. A new landmark study on the treatment of adolescent depression. Comments on the TADS study.
    Apter A, Kronenberg S, Brent D.
    Eur Child Adolesc Psychiatry; 2005 May 08; 14(3):113-6. PubMed ID: 15959656
    [No Abstract] [Full Text] [Related]

  • 16. [A place for SSRIs in the treatment of severely depressed children and adolescents].
    Roobol TH, Buitelaar JK.
    Ned Tijdschr Geneeskd; 2008 Aug 02; 152(31):1710-2. PubMed ID: 18727599
    [Abstract] [Full Text] [Related]

  • 17. [Evidence for psychopharmacological treatment of depression in children and adolescents?].
    Thomsen PH, Sørensen MJ.
    Ugeskr Laeger; 2007 Apr 02; 169(14):1289-94. PubMed ID: 17437688
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological management of treatment-resistant pediatric depression.
    Kratochvil CJ, Wagner KD, Emslie G, March J.
    J Am Acad Child Adolesc Psychiatry; 2005 Feb 02; 44(2):198-200. PubMed ID: 15689734
    [No Abstract] [Full Text] [Related]

  • 19. Fluoxetine in adolescents with major depression and an alcohol use disorder: an open-label trial.
    Cornelius JR, Bukstein OG, Birmaher B, Salloum IM, Lynch K, Pollock NK, Gershon S, Clark D.
    Addict Behav; 2001 Feb 02; 26(5):735-9. PubMed ID: 11676382
    [Abstract] [Full Text] [Related]

  • 20. After TADS, can we measure up, catch up, and ante up?
    Jensen PS.
    J Am Acad Child Adolesc Psychiatry; 2006 Dec 02; 45(12):1456-60. PubMed ID: 17135990
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.